T1002	pharmacokinetics 54 64	absorption
T1007	pharmacokinetics 160 176	pharmacokinetics
T10010	dosage 327 339	single doses
T10020	mealTime 640 651	food intake
T10025	pharmacokinetics 729 732	AUC
T10028	mealTime 799 804	after
T10031	mealTime 943 954	food intake
T10032	pharmacokinetics 962 978	pharmacokinetics
T10036	pharmacokinetics 1184 1194	absorption
T10041	pharmacokinetics 1371 1381	absorption
T10043	food 1444 1457	milk products
T10061	mealTime 68 85	concurrent intake
T10062	mealTime 1254 1264	taken with
T2003	food 89 93	milk
T2004	food 98 102	food
T2005	food 139 143	milk
T2006	food 148 152	food
T2008	drug 180 202	estramustine phosphate
T2009	studyType 264 301	randomized three-way cross-over study
T20013	food 406 410	milk
T20014	pharmacokinetics 446 466	plasma concentration
T20015	drug 487 499	estromustine
T20016	pharmacokinetics 565 569	tmax
T20017	drug 586 598	estromustine
T20018	interaction 618 627	increased
T20019	food 631 635	milk
T20021	pharmacokinetics 656 660	Cmax
T20022	pharmacokinetics 665 668	AUC
T20023	interaction 688 697	decreased
T20024	food 718 723	water
T20026	drug 736 748	estromustine
T20027	food 786 790	milk
T20029	mode 818 824	intake
T20030	food 934 938	milk
T20033	drug 982 989	estrone
T20034	drug 1057 1088	estramustine phosphate disodium
T20037	drug 1198 1220	estramustine phosphate
T20038	interaction 1226 1235	decreased
T20039	food 1265 1269	milk
T20040	food 1273 1277	food
T20042	food 1438 1442	milk
T2001	drug 31 53	estramustine phosphate
T20046	treatedDisease 241 257	prostatic cancer
T20047	drug 504 511	estrone
T20048	pharmacokinetics 574 582	lag time
T20049	value 753 756	41%
T20050	value 795 798	67%
T20053	drug 1385 1393	Estracyt
T20055	interaction 17 27	Impairment
T20058	pharmacokinetics 877 888	peak values
T20059	value 894 905	32 and 57%,
T20028	studyType 1003 1019	Studies in vitro
T20052	component 1130 1137	calcium
T20061	interaction 1289 1337	formation of a poorly absorbable calcium complex
T20045	population 223 257	six patients with prostatic cancer
T20012	meal 385 401	low calcium food
T20011	meal 366 383	low calcium water
T20056	mealTime 352 360	together
T20051	meal 828 845	standardized food
T20064	food 943 947	food
T20035	interaction 1093 1110	markedly impaired
T20044	meal 1467 1484	calcium-rich food
T20060	pharmacokinetics 1042 1088	dissolution of estramustine phosphate disodium
T20068	mealTime 775 790	taken with milk
T1	mealTime 805 824	simultaneous intake
T2	pertinence 1418 1431	taken togethe
#1	AnnotatorNotes T2	avis : doit on inclure should not ou pas 
R1	increase_pharmacokinetic_parameter Arg1:T20019 Arg2:T20017	
R2	absorption_decrease Arg1:T20052 Arg2:T20034	
R3	absorption_decrease Arg1:T20039 Arg2:T20037	
#2	AnnotatorNotes R1	Relation à supprimer car dans une même phrase, "augmentation" et "diminution" de paramètres pharmacocinétiques
